• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Curium Partners with PeptiDream for Prostate Cancer Theranostics

    GLOBENEWSWIRE

    NCC, PeptiDream: 64Cu-PD-32766 First Dosing In Renal Cell Carcinoma

    BUSINESSWIRE

    PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis

    BUSINESSWIRE

    Novartis pays PeptiDream $180M as radiopharma big bang continues

    FIERCE BIOTECH

    PeptiDream Announces Collaboration and License Agreement with Genentech

    BUSINESSWIRE

    PeptiDream Announces Nomination of Second Peptide Radiopharmaceutical Therapeutic Development Candidate

    BUSINESSWIRE

    PeptiDream Announces New Research and Collaboration Agreement with Lilly

    BUSINESSWIRE

    PeptiDream and RayzeBio Expand Alliance on Peptide-Radiotherapeutics

    PRESS RELEASE

    PeptiGrowth Inc. is Launching A Novel Synthetic Peptide BMP4,7 inhibitor (Noggin-like peptide)

    PRESS RELEASE

    PeptiAid Co., Ltd. Announces the Progress of Clinical Research on the New Coronavirus Infection Drug PA-001

    CMOCRO

    BIOHAVEN ENROLLS PHASE 1A/1B CLINICAL TRIAL OF BHV-1100, LEAD ASSET ITS ARM™

    BIOHAVENPHARMA

    Japan`s Fujifilm sells radiopharma biz to PeptiDream for 30.5 billion yen

    BIOSPECTRUM ASIA

    PeptiDream signs licensing deal with Alnylam worth up to $2.2B

    FIERCEBIOTECH

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.